Dietary approaches for exploiting metabolic vulnerabilities in cancer

Menyhárt, Otília and Győrffy, Balázs (2024) Dietary approaches for exploiting metabolic vulnerabilities in cancer. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1879 (2). No. 189062. ISSN 0304-419X

Preview	Text dietary.pdf - Published Version Available under License Creative Commons Attribution. Download (2MB) | Preview
Preview	Text (graphical abstract) 1-s2.0-S0304419X23002111-ga1_lrg.jpg - Published Version Available under License Creative Commons Attribution. Download (175kB) | Preview

Abstract

Renewed interest in tumor metabolism sparked an enthusiasm for dietary interventions to prevent and treat cancer. Changes in diet impact circulating nutrient levels in the plasma and the tumor microenvironment, and preclinical studies suggest that dietary approaches, including caloric and nutrient restrictions, can modulate tumor initiation, progression, and metastasis. Cancers are heterogeneous in their metabolic dependencies and preferred energy sources and can be addicted to glucose, fructose, amino acids, or lipids for survival and growth. This dependence is influenced by tumor type, anatomical location, tissue of origin, aberrant signaling, and the microenvironment. This review summarizes nutrient dependencies and the related signaling pathway activations that provide targets for nutritional interventions. We examine popular dietary approaches used as adjuvants to anticancer therapies, encompassing caloric restrictions, including time-restricted feeding, intermittent fasting, fasting-mimicking diets (FMDs), and nutrient restrictions, notably the ketogenic diet. Despite promising results, much of the knowledge on dietary restrictions comes from in vitro and animal studies, which may not accurately reflect real-life situations. Further research is needed to determine the optimal duration, timing, safety, and efficacy of dietary restrictions for different cancers and treatments. In addition, well-designed human trials are necessary to establish the link between specific metabolic vulnerabilities and targeted dietary interventions. However, low patient compliance in clinical trials remains a significant challenge.

Actions (login required)

View Item